In its April 2019 NEWSletter, the Patented Medicine Prices Review Board (PMPRB) announced that the Steering Committee on Guidelines Modernization would hold its final meeting on May 13, 2019, to discuss both a draft report of its deliberations and the Working Group’s final report (released March 6, 2019). Once the Steering Committee’s report has been finalized and the regulatory amendments have been published in Part II of the Canada Gazette (expected this spring), the PMPRB will release its draft Guidelines for public consultation.
Related Publications & Articles
-
FCA sets aside PMPRB’s order that Galderma’s patent claiming 0.3% adapalene “pertained to” 0.1% adapalene DIFFERIN
On December 3, 2024, the Federal Court of Appeal (FCA) set aside the order of the Patented Medicine Prices Review Board (PMPRB or Board) that had required Galderma to continue to provide information t...Read More -
Certificate of Supplementary Protection filing fee increase effective April 1, 2025
On April 1, 2025, the fee for filing a Certificate of Supplementary Protection will increase by 2% from $10,356 to $10,564.Read More -
PMPRB releases 2023 Annual Report
On December 6, 2024, the Minister of Health tabled the 2023 Annual Report of the Patented Medicine Prices Review Board (PMPRB).Read More